Hypertrophic Cardiomyopathy
📧 Sign up to get email alerts when something new happens for Hypertrophic Cardiomyopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-21Clinical Trial Update: Effectiveness and Treatment Patterns of Mavacamten in Patients With Obstructive Hypertrophic Cardiomyopathy in Japan (MANAGE-HCM)
This clinical trial update covers mavacamten for obstructive hypertrophic cardiomyopathy in Japan. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Perfusion Abnormalities in Hypertrophic Cardiomyopathy
This clinical trial update reports on perfusion abnormalities in hypertrophic cardiomyopathy; the study is currently active but not recruiti…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM). [Phase 2, Phase 3]
Cytokinetics is conducting a Phase 2/3 clinical trial to evaluate aficamten in pediatric patients with symptomatic obstructive hypertrophic …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
A study to assess the real-world effectiveness of mavacamten in adult patients with obstructive hypertrophic cardiomyopathy in China is curr…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Mechanisms of Atrial Pathoelectrophysiology in HCM
Clinical trial update investigating the mechanisms of atrial pathoelectrophysiology in hypertrophic cardiomyopathy and atrial fibrillation; …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM [Phase 1, Phase 2]
Tenaya Therapeutics announced a multi-center, open-label Phase 1/2 trial to evaluate safety and tolerability of TN-201 in adults with MYBPC3…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Valsalva SBP Drop and LVOT Obstruction
This clinical trial update notes a Valsalva-induced drop in systolic blood pressure and left ventricular outflow tract obstruction in hypert…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: A Study of Artificial Intelligence ECG With ECG Devices to Detect Hypertrophic Cardiomyopathy Distinct From Athlete's
This clinical trial evaluates an artificial intelligence-enabled ECG approach using ECG devices to distinguish hypertrophic cardiomyopathy f…
-
CLINICAL_TRIALS research · 2026-03-18Clinical Trial Update: HCMR Re-Imaging Study
The HCMR Re-Imaging Study is currently recruiting participants for Hypertrophic Cardiomyopathy.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Catheter Ablation Versus Anti-arrhythmic Drugs for Ventricular Tachycardia [NA]
Clinical trial update comparing catheter ablation to anti-arrhythmic drugs for ventricular tachycardia is active but not recruiting, involvi…
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases [Phase 1, Phase 2]
This clinical trial update reports ongoing Phase 1/2 studies evaluating the Ga-68-labeled NI-FAPI-04 PET/CT imaging agent for fibroblast act…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER) [Phase 4]
A Phase 4 clinical trial in India evaluating mavacamten for symptomatic obstructive hypertrophic cardiomyopathy is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy [Phase 3]
A Phase 3 clinical trial evaluating the efficacy and safety of sotagliflozin in symptomatic hypertrophic cardiomyopathy, including both obst…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: Biological Collection for the Purpose of Exploring Genetic and Clinical-biological Factors Associated With Variability in Response to Mavacamten in the Treatment of Obstructive Hypertrophic Cardiomyopathy
This clinical trial update describes a biological sample collection study to explore genetic and clinical-biological factors that influence …
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: French Registry: Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy
This ClinicalTrials.gov registry update indicates that the French study on Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy is not…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Study of the Progression of Chronic Cardiovascular Conditions
Clinical trial is currently recruiting to study the progression of chronic cardiovascular conditions, including heart failure, hypertension,…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Precision Pharmacogenetics and Genotype Class Based Prediction of Mavacamten Response in Obstructive Hypertrophic Cardiomyopathy
This clinical trial update describes a study on precision pharmacogenetics and genotype-based prediction of mavacamten response in obstructi…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Sodium Glucose Co-transporter (SGLT) Inhibitors in Nonobstructive Hypertrophic Cardiomyopathy [EARLY_Phase 1]
Early-phase clinical trial evaluating sodium-glucose cotransporter (SGLT) inhibitors for nonobstructive hypertrophic cardiomyopathy; recruit…
-
CLINICAL_TRIALS research · 2026-02-05Clinical Trial Update: A Prospective Incident Study of Arrhythmias in Hypertrophic Cardiomyopathy
This update describes a prospective incident study of arrhythmias in hypertrophic cardiomyopathy, sponsored by Mayo Clinic. The trial is cur…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic nHCM [Phase 3]
A Phase 3 trial evaluating Aficamten versus placebo for symptomatic non-obstructive hypertrophic cardiomyopathy is ongoing but not currently…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes
A recruiting clinical trial evaluating myocardial perfusion cardiac MRI to differentiate and characterize hypertrophic cardiomyopathy phenot…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Multicentre Hypertrophic Cardiomyopathy Registry
A multicentre registry study for hypertrophic cardiomyopathy is listed as not yet recruiting.
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Left Bundle Branch Pacing in Patients With Hypertrophic Cardiomyopathy After Myectomy [NA]
A ClinicalTrials.gov update shows a recruiting study evaluating left bundle branch pacing in patients with hypertrophic cardiomyopathy after…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: One-stop Evaluation of Hypertrophic Cardiomyopathy in Cardiac Magnetic Resonance
This entry reports an ongoing clinical study titled 'One-stop Evaluation of Hypertrophic Cardiomyopathy in Cardiac Magnetic Resonance,' spon…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM [Phase 2, Phase 3]
Open-label extension study to assess the long-term safety and tolerability of aficamten in adults with hypertrophic cardiomyopathy. The tria…